513 studies found for:    "chronic graft versus host disease"
Show Display Options
Rank Status Study
1 Terminated Positron Emission Tomography - Computed Tomography (PET-CT) Scanning in Chronic Graft Versus Host Disease (cGvHD)
Condition: Chronic Graft Versus Host Disease
Intervention: Other: PET-CT Scan
2 Recruiting Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease
Condition: Chronic Graft Versus Host Disease
Intervention: Drug: Ofatumumab
3 Recruiting Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)
Conditions: Chronic Graft-Versus-Host Disease;   Acute Graft-Versus-Host Disease;   Steroid Refractory Graft-Versus-Host Disease
Interventions: Drug: Rapamycin;   Other: T regulatory cells
4 Completed Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children
Condition: Graft vs Host Disease
Intervention: Drug: Pentostatin
5 Unknown  Study of Rituximab in Patients With Steroid-Refractory Chronic Graft-Versus-Host Disease
Condition: Steroid-Refractory Chronic GVHD
Intervention: Drug: Rituximab
6 Unknown  Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Chronic Graft Versus Host Disease
Condition: Chronic Graft Versus Host Disease
Interventions: Biological: Biological: mesenchymal stem cell;   Drug: Cyclosporine and Glucocorticoid
7 Recruiting Trial of Regulatory T-cells Plus Low-Dose Interleukin-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
Conditions: Chronic Graft Versus Host Disease;   Chronic GVHD;   Complications of Organ Transplant Stem Cells
Interventions: Other: Treg-enriched infusion;   Drug: Interleukin-2
8 Active, not recruiting Rituximab for the Primary Treatment of Denovo Extensive Chronic Graft Versus Host Disease (GVHD)
Condition: Chronic Graft-versus-host Disease
Intervention: Drug: Rituximab
9 Terminated
Has Results
Alefacept in Subjects With Steroid-Refractory Chronic Graft-versus-Host Disease
Condition: Chronic Graft-versus-host Disease
Intervention: Drug: Alefacept
10 Recruiting Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
Condition: Chronic GVHD
Interventions: Drug: Sirolimus + calcineurin inhibitor + prednisone;   Drug: Sirolimus + prednisone
11 Withdrawn Pentostatin, Cyclophosphamide Plus Rituximab (PCR) for the Therapy of Poor-Prognosis Chronic Graft-Versus-Host Disease
Condition: Active Chronic Graft Versus Host Disease
Intervention: Drug: Pentostatin; Cyclophosphamide; Rituximab
12 Recruiting A Safety and Efficacy Study of Uvadex and Extracorporeal Photopheresis (ECP) in Chronic Graft Versus Host Disease
Condition: Chronic Graft Versus Host Disease
Interventions: Drug: ECP(Methoxsalen)+Corticosteroids+Cyclosporine or Tacrolimus;   Drug: Corticosteroids/Cyclosporine/Tacrolimus
13 Recruiting Mesenchymal Stem Cells for Treatment of Refractory Chronic Graft-versus-host Disease
Condition: Chronic Graft-versus-host Disease
Interventions: Biological: Mesenchymal stem cells;   Biological: Non-mesenchymal stem cells
14 Active, not recruiting Improving Outcomes Assessment in Chronic GVHD
Condition: Chronic Graft Versus Host Disease
Intervention:
15 Unknown  Treatment of Chronic GVHD of Liver or Lungs by ECP
Condition: Chronic Graft-Versus Host Disease
Intervention: Procedure: Extracorporeal photoimmunotherapy
16 Completed
Has Results
Bortezomib Plus Prednisone for Initial Therapy of Chronic Graft Versus Host Disease
Condition: Chronic Graft Versus Host Disease
Interventions: Drug: bortezomib;   Drug: Prednisone
17 Withdrawn A Study of Panobinostat (LBH589) as Second-Line Therapy in Patients With Chronic Graft-Versus-Host Disease
Condition: Chronic Graft-Versus-Host Disease
Interventions: Drug: LBH589;   Drug: Methylprednisolone
18 Unknown  Prospective Phase II Study for Assessment of Regulatory Immune Cell Populations After Allogeneic HSCT
Condition: Allogeneic Hematopoietic Cell Transplant Recipients
Intervention:
19 Completed Development and Validation of a Symptom Scale for Children With Chronic Graft-versus-Host Disease
Condition: Chronic Graft-Versus-Host-Disease
Intervention:
20 Completed Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease
Conditions: Graft vs Host Disease;   Blood and Marrow Transplant (BMT)
Intervention: Procedure: high dose chemotherapy and autologous hematopoietic cell transplant

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years